Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Inventory Average (2016 - 2025)

Cytosorbents' Inventory Average history spans 14 years, with the latest figure at $4.6 million for Q4 2025.

  • Quarterly results put Inventory Average at $4.6 million for Q4 2025, up 55.21% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (up 55.21% YoY), and the annual figure for FY2025 was $4.0 million, up 31.19%.
  • Inventory Average for Q4 2025 was $4.6 million at Cytosorbents, up from $3.9 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $5.2 million in Q2 2022 to a low of $1.9 million in Q2 2023.
  • The 5-year median for Inventory Average is $3.5 million (2022), against an average of $3.6 million.
  • The sharpest move saw Inventory Average tumbled 63.82% in 2023, then soared 113.58% in 2024.
  • Year by year, Inventory Average stood at $4.6 million in 2021, then decreased by 24.65% to $3.5 million in 2022, then fell by 9.28% to $3.2 million in 2023, then fell by 5.86% to $3.0 million in 2024, then surged by 55.21% to $4.6 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $4.6 million, $3.9 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.